A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

NCT06474455 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-9839 for Injection
DRUG: SHR-A1921 for Injection
DRUG: SHR-A2009 for Injection
DRUG: Almonertinib Mesilate Tablets
DRUG: Pemetrexed Disodium for Injection
DRUG: Carboplatin for injection
DRUG: Paclitaxel injection
DRUG: SHR-1316 Injection
DRUG: SHR-9839 for Injection (sc)

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.